Serum tumor marker CA 125 for monitoring ovarian cancer during follow-up

Author： Tuxen M. K. SöLétormos G. Dombernowsky P.

ISSN： 0036-5513

Source： Scandinavian Journal of Clinical and Laboratory Investigation, Vol.62, Iss.3, 2002-05, pp. : 177-188

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of Serum Tumor Markers for the Diagnosis and Follow-Up of Breast Cancer

Oncology, Vol. 55, Iss. 5, 1998-08 ,pp. : 447-449

Karger

Access to resources Recommend Favorite

Elevated Serum CA-125 in a Patient with Follicular Lymphoma and a History of Ovarian Cancer

Case Reports in Oncology, Vol. 4, Iss. 1, 2011-03 ,pp. : 172-174

Karger

Access to resources Recommend Favorite

Assessing Prognosis in Metastatic Pancreatic Cancer by the Serum Tumor Marker CA 19-9: Pretreatment Levels or Kinetics during Chemotherapy?

Oncology Research and Treatment, Vol. 30, Iss. 1-2, 2007-01 ,pp. : 39-42

Karger

Access to resources Recommend Favorite

CYFRA21-1 as a serum tumor marker for follow-up patients with squamous cell lung carcinoma and oropharynx squamous cell carcinoma

By Liu Lei Liu Bin Zhu Li-li Li Yu

Biomarkers in Medicine, Vol. 7, Iss. 4, 2013-08 ,pp. : 591-599

Future Medicine

Access to resources Recommend Favorite

CA-125 Monitoring in Ovarian Cancer: Patient Survey Responses to the Results of the MRC/EORTC CA-125 Surveillance Trial

Oncology, Vol. 78, Iss. 1, 2010-03 ,pp. : 1-2

Karger

Access to resources Recommend Favorite